
AI-generated summary
The Dax closed at 26,046 points on Friday after losing over 700 points at the beginning of the previous week.
Dusseldorf. The Dax started trading on Monday 0.3 percent lower at 25,976 points. Due to Labor Day in the USA, the stock exchanges there will remain closed today - which means that no major movements on the Dax are expected during the day.
On Friday, the Dax closed at 26,046 points, almost unchanged from the previous day. After three days of losses at the beginning of last week, in which the index lost a total of over 700 points, it stabilized somewhat at the weekend. Finally, it was able to overcome the 26,000 point mark and hold it for two days in a row.
It still seems completely unclear whether the leading index can stay above the mark this week. “Even if investors have obviously been able to shake off the worry cocktail of geopolitical and monetary policy imponderables for the time being, the situation is likely to remain fragile,” says CapTrader chief market analyst Timo Emden.
While there were increasing signals last week pointing to a possible easing of tensions in the Middle East, over the weekend there were again mutual attacks by the USA and Iran on ships in the Strait of Hormuz. Investors are therefore focusing on the persistently high oil prices: concerns about a long-term interruption of oil supplies from the Middle East are increasing.
The VW factory in Osnabrück is to be sold to the investor Aurelius and the state of Lower Saxony in order to become a center for defense technology. A cooperation with the Israeli arms company Rafael for air defense systems is planned.

The Volkswagen factory in Osnabrück will stop producing passenger cars and will in future produce components for air defense systems. An agreement with the Israeli defense company Rafael and Aurelius Capital is intended to secure 1,400 of the 1,800 jobs in the long term.

By 2029, there could be a shortage of around 723,000 skilled workers in Germany, almost twice as many as in 2025. Sales, childcare and social professions are particularly affected. The IW cites the retirement of baby boomers as the main reasons.

Novartis is ending the clinical trial for the heart drug pelacarsen because the active ingredient did not provide significant protection against heart attacks or strokes. The shares of the Swiss group and those of its partner Ionis Pharmaceuticals came under pressure.

The major reinsurers Munich Re, Swiss Re and Hannover Re are warning at the industry meeting in Monte Carlo of increasing losses from climate-related natural disasters such as forest fires, droughts and hail, which are increasingly putting strain on the global infrastructure.

Novartis shares fall after disappointing trial results for heart drug pelacarsen. The drug, developed together with Ionis Pharmaceuticals, was unable to significantly reduce the risk of heart attacks and strokes despite reducing lipoprotein(a) levels.